TRA GLI INTONACI MEDIEVALI Dl UN'ALTRA LOMBARDIA. La pittura murale dell'XI-XIII secolo in Canton Ticino

Cette thèse a pour objet l'étude de la peinture murale des Xle-Xllle siècles dans l'actuel Canton du Tessin. A cette époque, la région qui compose ce territoire ne constituait pas une unité, mais formait les contrées plus éloignées, adossées au massif central des Alpes, des; villes et des diocèses de Côme et Milan. L'histoire de ses limites territoriales et politiques a déterminé aussi l'orientation de l'histoire des études: l'actuel Canton du Tessiri n'a pas vraiment été considéré ni par les chercheurs qui se sont occupés de la Lombardie, ni par ceux qui se sont occupés de la Suisse: d'une part, car aujourd'hui il ne fait plus partie de la Lombardie, de l'autre, parce qu'à l'époque médiévale il ne faisait pas encore partie du territoire suisse. On a donc affaire à un sujet d'étude marginalisé, qui a pendant longtemps aussi souffert de la marginalité historiographique du Tessin médiéval, considéré comme une région culturellement «en retard» par rapport aux centres de Côme et Milan. À travers le filtre historiographique naît ainsi l'exigence d'étudier ce territoire de manière cohérente, tout en étant conscient de sa fragmentation à l'époque médiévale. Par le recensement et l'analyse de tous les témoignages picturaux des XP-Xllle siècles existants ou désormais disparus, mais pour lesquels subsiste de la documentation visuelle, nous avons essayé de dresser la physionomie artistique de cette région: il s'agissait non seulement de définir leur relations avec les éléments lombards proches, mais dans l'ensemble qu'ils composent avec ceux-ci. Et c'est justement cette unité entre la réalité lombarde et celle tessinoise que, dans la limite du possible, nous avons cherché à recomposer dans ce travail. A cause de sa longue durée, l'arc chronologique choisi s'est révélé fondamental pour saisir les dynamiques et les mécanismes - indispensables, par exemple, pour comprendre le rapport entre centre et périphérie ou la géographie artistique du territoire considéré - qui échapperaient à un regard chronologique plus restreint. Cette contextualisation a mené à une ouverture ultérieure. Historiquement replacés à l'intérieur du panorama pictural lombard, les témoignages tessinois ont été l'objet d'une mise eri perspective plus large qui a permis - quand cela était possible - de les insérer dans la culture artistique contemporaine. Traversée par certaines parmi les plus importantes voies de communication reliant le Nord et le Sud des Alpes, la condition liminaire de cette région ne semble pas avoir conditionné de manière déterminante ses échanges avec d'autres réalités: elle n'apparaît ni plus réceptive, ni plus imperméable que d'autres régions lombardes envers les différents horizons culturels sur lesquels la Lombardie était ouverte, se nourrissant d'apports variés. Les points de contact relevés fournissent des précieux indices sur le fonctionnement des ateliers, sur la circulation des modèles et sur les commanditaires. Ces différents niveaux d'analyse déterminent la structure du travail: le catalogue d'oeuvres examinées - organisé en fiches ordonnées selon la chronologie établie sur la base des résultats apparus lors de l'analyse historique-artistique - est précédé par une partie introductive plus discursive. Cette dernière met en évidence et analyse les émergences principales, situant les ensembles étudiés entre eux et à l'intérieur de l'époque à laquelle ils appartiennent. La définition de la physionomie artistique de la région tessinoise apporte ainsi de nouveaux repères non seulement dans la connaissance de l'art des siècles centraux du Moyen Âge Lombard, mais aussi du vaste espace alpin situé au coeur de l'Occident médiéval.

Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering.

BACKGROUND: Lipid-lowering therapy is costly but effective at reducing coronary heart disease (CHD) risk. OBJECTIVE: To assess the cost-effectiveness and public health impact of Adult Treatment Panel III (ATP III) guidelines and compare with a range of risk- and age-based alternative strategies. DESIGN: The CHD Policy Model, a Markov-type cost-effectiveness model. DATA SOURCES: National surveys (1999 to 2004), vital statistics (2000), the Framingham Heart Study (1948 to 2000), other published data, and a direct survey of statin costs (2008). TARGET POPULATION: U.S. population age 35 to 85 years. Time Horizon: 2010 to 2040. PERSPECTIVE: Health care system. INTERVENTION: Lowering of low-density lipoprotein cholesterol with HMG-CoA reductase inhibitors (statins). OUTCOME MEASURE: Incremental cost-effectiveness. RESULTS OF BASE-CASE ANALYSIS: Full adherence to ATP III primary prevention guidelines would require starting (9.7 million) or intensifying (1.4 million) statin therapy for 11.1 million adults and would prevent 20,000 myocardial infarctions and 10,000 CHD deaths per year at an annual net cost of $3.6 billion ($42,000/QALY) if low-intensity statins cost $2.11 per pill. The ATP III guidelines would be preferred over alternative strategies if society is willing to pay $50,000/QALY and statins cost $1.54 to $2.21 per pill. At higher statin costs, ATP III is not cost-effective; at lower costs, more liberal statin-prescribing strategies would be preferred; and at costs less than $0.10 per pill, treating all persons with low-density lipoprotein cholesterol levels greater than 3.4 mmol/L (>130 mg/dL) would yield net cost savings. RESULTS OF SENSITIVITY ANALYSIS: Results are sensitive to the assumptions that LDL cholesterol becomes less important as a risk factor with increasing age and that little disutility results from taking a pill every day. LIMITATION: Randomized trial evidence for statin effectiveness is not available for all subgroups. CONCLUSION: The ATP III guidelines are relatively cost-effective and would have a large public health impact if implemented fully in the United States. Alternate strategies may be preferred, however, depending on the cost of statins and how much society is willing to pay for better health outcomes. FUNDING: Flight Attendants' Medical Research Institute and the Swanson Family Fund. The Framingham Heart Study and Framingham Offspring Study are conducted and supported by the National Heart, Lung, and Blood Institute.

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.

OBJECTIVE: To provide an update to the original Surviving Sepsis Campaign clinical management guidelines, "Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis and Septic Shock," published in 2004. DESIGN: Modified Delphi method with a consensus conference of 55 international experts, several subsequent meetings of subgroups and key individuals, teleconferences, and electronic-based discussion among subgroups and among the entire committee. This process was conducted independently of any industry funding. METHODS: We used the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) system to guide assessment of quality of evidence from high (A) to very low (D) and to determine the strength of recommendations. A strong recommendation (1) indicates that an intervention's desirable effects clearly outweigh its undesirable effects (risk, burden, cost) or clearly do not. Weak recommendations (2) indicate that the tradeoff between desirable and undesirable effects is less clear. The grade of strong or weak is considered of greater clinical importance than a difference in letter level of quality of evidence. In areas without complete agreement, a formal process of resolution was developed and applied. Recommendations are grouped into those directly targeting severe sepsis, recommendations targeting general care of the critically ill patient that are considered high priority in severe sepsis, and pediatric considerations. RESULTS: Key recommendations, listed by category, include early goal-directed resuscitation of the septic patient during the first 6 hrs after recognition (1C); blood cultures before antibiotic therapy (1C); imaging studies performed promptly to confirm potential source of infection (1C); administration of broad-spectrum antibiotic therapy within 1 hr of diagnosis of septic shock (1B) and severe sepsis without septic shock (1D); reassessment of antibiotic therapy with microbiology and clinical data to narrow coverage, when appropriate (1C); a usual 7-10 days of antibiotic therapy guided by clinical response (1D); source control with attention to the balance of risks and benefits of the chosen method (1C); administration of either crystalloid or colloid fluid resuscitation (1B); fluid challenge to restore mean circulating filling pressure (1C); reduction in rate of fluid administration with rising filing pressures and no improvement in tissue perfusion (1D); vasopressor preference for norepinephrine or dopamine to maintain an initial target of mean arterial pressure > or = 65 mm Hg (1C); dobutamine inotropic therapy when cardiac output remains low despite fluid resuscitation and combined inotropic/vasopressor therapy (1C); stress-dose steroid therapy given only in septic shock after blood pressure is identified to be poorly responsive to fluid and vasopressor therapy (2C); recombinant activated protein C in patients with severe sepsis and clinical assessment of high risk for death (2B except 2C for postoperative patients). In the absence of tissue hypoperfusion, coronary artery disease, or acute hemorrhage, target a hemoglobin of 7-9 g/dL (1B); a low tidal volume (1B) and limitation of inspiratory plateau pressure strategy (1C) for acute lung injury (ALI)/acute respiratory distress syndrome (ARDS); application of at least a minimal amount of positive end-expiratory pressure in acute lung injury (1C); head of bed elevation in mechanically ventilated patients unless contraindicated (1B); avoiding routine use of pulmonary artery catheters in ALI/ARDS (1A); to decrease days of mechanical ventilation and ICU length of stay, a conservative fluid strategy for patients with established ALI/ARDS who are not in shock (1C); protocols for weaning and sedation/analgesia (1B); using either intermittent bolus sedation or continuous infusion sedation with daily interruptions or lightening (1B); avoidance of neuromuscular blockers, if at all possible (1B); institution of glycemic control (1B), targeting a blood glucose < 150 mg/dL after initial stabilization (2C); equivalency of continuous veno-veno hemofiltration or intermittent hemodialysis (2B); prophylaxis for deep vein thrombosis (1A); use of stress ulcer prophylaxis to prevent upper gastrointestinal bleeding using H2 blockers (1A) or proton pump inhibitors (1B); and consideration of limitation of support where appropriate (1D). Recommendations specific to pediatric severe sepsis include greater use of physical examination therapeutic end points (2C); dopamine as the first drug of choice for hypotension (2C); steroids only in children with suspected or proven adrenal insufficiency (2C); and a recommendation against the use of recombinant activated protein C in children (1B). CONCLUSIONS: There was strong agreement among a large cohort of international experts regarding many level 1 recommendations for the best current care of patients with severe sepsis. Evidenced-based recommendations regarding the acute management of sepsis and septic shock are the first step toward improved outcomes for this important group of critically ill patients.